Skip to main content
Equibles
BLFS logo

BLFS · Biolife Solutions Inc · Webcasts, Transcripts & Audio

Track BLFS — free

Use BLFS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BLFS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$37.30 +0.52 (+1.41%) At close · Oct 2
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.92B
Shares
48.91M
Volume · Oct 2 2.85M Avg daily vol (3M) 1.07M

Biolife Solutions Inc Webcasts

Earnings calls, investor updates, investor days and conferences for Biolife Solutions Inc (BLFS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲29.9% $40.53M −$72.88M '22 Q2 22-08-09 ▲20.6% $40.75M −$10.32M '22 Q3 22-11-09 ▼210.6% $ −$49.19M '22 Q4 23-03-16 ▲4.1% $37.70M −$13.71M '23 Q1 23-05-10 ▼27.9% $29.24M −$10.20M '23 Q2 23-08-08 ▼42.1% $23.57M −$29.13M '23 Q3 23-10-23 · $ −$14.96M '23 Q4 24-01-08 ▼51.1% $18.43M −$10.22M '24 Q1 24-05-09 ▼32.6% $19.71M −$20.72M '24 Q2 24-08-08 ▼9.3% $21.39M −$1.70M '24 Q3 24-11-12 · $15.11M $12.46M '24 Q4 24-12-31 ▲19.6% $22.05M −$448,000 '25 Q1 25-05-08 ▲18.9% $23.44M −$15.84M '25 Q2 25-08-07 ▲31.2% $28.07M $621,000 '25 Q3 25-11-06 ▲50% $22.66M $11.07M '25 Q4 26-02-26 LATEST ▲24.7% $27.50M $1.19M '26 Q1 26-05-07
Earnings call
FY26 · Q1
2026-05-07
Biolife Solutions Inc (BLFS) Q1 2026 Earnings Call Transcript
Confident tone Biopreservation Media (BPM) Growth Homebrew Conversion Opportunity Gross Margin / Bag Yield Issue
Revenue
$27.50M
▲ 24.7% YoY
Diluted EPS
$0.02
Gross margin
63.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Biolife Solutions Inc (BLFS) Q4 2025 Earnings Call Transcript
Confident tone Strategic Partnerships & M&A (Qkine, Panthera, Pluristics) 2026 Financial Guidance & Profitability Cell & Gene Therapy (CGT) Market Opportunity
Revenue
$22.66M*
▲ 50% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Biolife Solutions Inc (BLFS) Q3 2025 Earnings Call Transcript
Confident tone Cell processing revenue growth Guidance raise and Q4 visibility Customer mix shift to commercial and direct sales
Revenue
$28.07M
▲ 31.2% YoY
Diluted EPS
$0.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Biolife Solutions Inc (BLFS) Q2 2025 Earnings Call Transcript
Confident tone Strategic acquisitions and investments Cell processing revenue growth Raised full-year guidance
Revenue
$23.44M
▲ 18.9% YoY
Diluted EPS
$-0.33
Gross margin
65.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Biolife Solutions Inc (BLFS) Q1 2025 Earnings Call Transcript
Confident tone Cell processing platform growth Commercial customer mix / revenue durability Tariffs and trade policy risk
Revenue
$22.05M
▲ 19.6% YoY
Diluted EPS
$0.00
Gross margin
67.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Biolife Solutions Inc (BLFS) Q4 2024 Earnings Call Transcript
Confident tone Cell Processing platform growth Product line expansion (Sxton consumables, CryoCase, CT5) Profitability and margin expansion
Revenue
$15.11M*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Biolife Solutions Inc (BLFS) Q3 2024 Earnings Call Transcript
Confident tone Cell processing platform growth SciSafe divestiture and portfolio streamlining Margin expansion and profitability
Revenue
$21.39M
▼ 9.3% YoY
Diluted EPS
$-0.04
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Biolife Solutions Inc (BLFS) Q2 2024 Earnings Call
Revenue
$19.71M
▼ 32.6% YoY
Diluted EPS
$-0.45
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Biolife Solutions Inc (BLFS) Q1 2024 Earnings Call Transcript
Confident tone GCI / CBS divestitures and portfolio rationalization Cell processing / biopreservation media growth Margin expansion and adjusted EBITDA
Revenue
$18.43M
▼ 51.1% YoY
Diluted EPS
$-0.22
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-01-08
Biolife Solutions Inc (BLFS) Q4 2023 Earnings Call Transcript
Positive tone Cell Processing Platform Performance 2024 Revenue Guidance Freezer Divestiture
Revenue
$*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-10-23
Biolife Solutions Inc (BLFS) Q3 2023 Earnings Call Transcript
Revenue
$23.57M
▼ 42.1% YoY
Diluted EPS
$-0.67
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Biolife Solutions Inc (BLFS) Q2 2023 Earnings Call Transcript
Revenue
$29.24M
▼ 27.9% YoY
Diluted EPS
$-0.23
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Biolife Solutions Inc (BLFS) Q1 2023 Earnings Call Transcript
Revenue
$37.70M
▲ 4.1% YoY
Diluted EPS
$-0.32
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-16
Biolife Solutions Inc (BLFS) Q4 2022 Earnings Call Transcript
Revenue
$*
▼ 210.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-09
Biolife Solutions Inc (BLFS) Q3 2022 Earnings Call Transcript
Revenue
$40.75M
▲ 20.6% YoY
Diluted EPS
$-0.24
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Biolife Solutions Inc (BLFS) Q2 2022 Earnings Call Transcript
Revenue
$40.53M
▲ 29.9% YoY
Diluted EPS
$-1.72
▼ 1005.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
Biolife Solutions Inc (BLFS) Q1 2022 Earnings Call Transcript
Revenue
$36.22M
▲ 115% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-28
Biolife Solutions Inc (BLFS) Q4 2021 Earnings Call Transcript
Revenue
$37.30M*
▲ 153.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Biolife Solutions Inc (BLFS) Q3 2021 Earnings Call Transcript
Revenue
$33.80M
▲ 199.7% YoY
Diluted EPS
$0.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Biolife Solutions Inc (BLFS) Q2 2021 Earnings Call Transcript
Revenue
$31.20M
▲ 214.6% YoY
Diluted EPS
$0.19
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Biolife Solutions Inc (BLFS) Q1 2021 Earnings Call Transcript
Revenue
$16.85M
▲ 38.5% YoY
Diluted EPS
$-0.03
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-22
Biolife Solutions Inc (BLFS) Q4 2020 Earnings Call Transcript
Revenue
$14.73M*
▲ 77.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Biolife Solutions Inc (BLFS) Q3 2020 Earnings Call Transcript
Revenue
$11.28M
▲ 70.8% YoY
Diluted EPS
$-0.04
▼ 111.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-02
Biolife Solutions Inc (BLFS) Q2 2020 Earnings Call Transcript
Revenue
$9.92M
▲ 48% YoY
Diluted EPS
$-0.70
▼ 3600% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-14
Biolife Solutions Inc (BLFS) Q1 2020 Earnings Call Transcript
Revenue
$12.16M
▲ 110.8% YoY
Diluted EPS
$-0.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-11
Biolife Solutions Inc (BLFS) Q4 2019 Earnings Call
Revenue
$8.30M*
▲ 52.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–26 of 26 webcasts
Key facts CIK 834365 CUSIP 09062W204 13F (30d) 6 filings 6 filers Visit website Investor relations